Copyright © 1993 by the European Society of Cardiology.
© 1993 The Europen Society of Cardiology
Two types of left ventricular wall motion abnormalities with distinct clinical features in patients with hypertrophic cardiomyopathy
Cardiovascular Center, Toranomon Hospital Minato-ku Toranomon 2-2-2, Tokyo, Japan
Received 1 March 1993; revised 25 June 1993; .
Correspondence Sugao Ishiwata, MD, Cardiovascular Center, Toranomon Hospital. Minato-ku Toranomon 2-2-2, Tokyo, 105, Japan
Abstract
During the long-term follow-up of patients with hypertrophic cardiomyopathy (HCM), some patients develop left ventricular (LV) wall motion abnormalities in the absence of fixed coronary artery disease. The purpose of this study is to clarify which clinical features in patients with HCM seem to influence gradual development of LV wall motion abnormalities over an extended period of time. The study investigates the incidence, mechanism and predictors of these abnormalities. In this retrospective study of 162 patients with HCM, followed-up for an average of 13.3 years, we focused our attention on 16 patients who gradually developed two different forms of LV wall motion abnormality. In 11 of these 16 patients, apical segmental dysfunction with midzone obstruction was recognized; the remaining five patients showed generalized hypokinesis, as seen in dilated cardiomyopathy. The 11 patients with apical segmental dysfunction presented with extensive apical hypertrophy reaching the midventricular level at first examination. The five patients with generalized hypokinesis showed a slight decrease in LV contractility and reduced localized antero-apical wall motion even at initial examination. None of the patients in either group developed the other group's features during their clinical course.
These two groups had different initial manifestations and pursued different clinical courses, suggesting that the underlying mechanisms causing wall motion abnormalities are different.
Key Words: Hypertrophic cardiomyopathy • long-term prognosis • apical dysfunction • dilated cardiomyopathy-like features
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. S. Maron, J. J. Finley, J. M. Bos, T. H. Hauser, W. J. Manning, T. S. Haas, J. R. Lesser, J. E. Udelson, M. J. Ackerman, and B. J. Maron Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy Circulation, October 7, 2008; 118(15): 1541 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsubara, T. Nakamura, T. Kuribayashi, A. Azuma, and M. Nakagawa Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy J. Am. Coll. Cardiol., July 16, 2003; 42(2): 288 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Eriksson, B. Sonnenberg, A. Woo, P. Rakowski, T. G. Parker, E. D. Wigle, and H. Rakowski Long-term outcome in patients with apical hypertrophic cardiomyopathy J. Am. Coll. Cardiol., February 20, 2002; 39(4): 638 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E D. Wigle CARDIOMYOPATHY: The diagnosis of hypertrophic cardiomyopathy Heart, December 1, 2001; 86(6): 709 - 714. [Full Text] [PDF]
|
|
|
|
|
|
E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment Circulation, October 1, 1995; 92(7): 1680 - 1692. [Full Text]
|
|